Etoricoxib in ankylosing spondylitis: is there a role for active patients refractory to traditional NSAIDs?


OBJECTIVES To evaluate the efficacy of etoricoxib in patients with axial ankylosing spondyloarthritis (AS) refractory to traditional NSAIDs. METHODS This was an open label, multicentric, randomised, prospective (4 weeks with and open extension to 6 months), non-controlled study. Consecutive patients with axial AS refractory to traditional NSAID eligible… (More)